Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 376  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
Read this article


    Article Cited by others


Vemurafenib-induced bilateral facial palsy

Shailesh FNU, Singh M, Tiwari U, Hutchins L F

Year : 2014| Volume: 60| Issue : 2 | Page no: 187-188

   This article has been cited by
1 Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature
Chiara Demichelis, Andrea Balestra, Caterina Lapucci, Angela Zuppa, Stefano G Grisanti, Valeria Prada, Giampaola Pesce, Ilaria Grasso, Paola Queirolo, Angelo Schenone, Luana Benedetti, Marina Grandis
Neurological Sciences. 2021; 42(4): 1405
[Pubmed]  [Google Scholar] [DOI]
2 Ocular Toxicity of Targeted Anticancer Agents
Blake H. Fortes, Prashant D. Tailor, Lauren A. Dalvin
Drugs. 2021; 81(7): 771
[Pubmed]  [Google Scholar] [DOI]
3 Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma
Andrew T. Li, Aung Min Maw, Edward Hsiao, Sydney Ch'ng, Georgina V. Long, Kerwin F. Shannon, Edwin J. Morrison
ANZ Journal of Surgery. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Nicholas S. Phillips, Elizabeth S. Duke, Hannah-Lise T. Schofield, Nicole J. Ullrich
Journal of Clinical Oncology. 2021; 39(16): 1752
[Pubmed]  [Google Scholar] [DOI]
5 Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review
Shruthi Harish Bindiganavile, Nita Bhat, Andrew G. Lee, Dan S. Gombos, Nagham Al-Zubidi
Journal of Immunotherapy and Precision Oncology. 2021; 4(1): 6
[Pubmed]  [Google Scholar] [DOI]
6 Acute polyneuropathy in a metastatic melanoma patient treated with vemurafenib and cobimetinib
Annette Compter, Willem Boogerd, Johannes V. van Thienen, Dieta Brandsma
Neurology: Clinical Practice. 2017; 7(5): 418
[Pubmed]  [Google Scholar] [DOI]
7 Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
Jean-Pierre Delord, Caroline Robert, Marta Nyakas, Grant A. McArthur, Ragini Kudchakar, Amit Mahipal, Yasuhide Yamada, Ryan Sullivan, Ana Arance, Richard F. Kefford, Matteo S. Carlino, Manuel Hidalgo, Carlos Gomez-Roca, Daniela Michel, Abdelkader Seroutou, Vassilios Aslanis, Giordano Caponigro, Darrin D. Stuart, Laure Moutouh-de Parseval, Tim Demuth, Reinhard Dummer
Clinical Cancer Research. 2017; 23(18): 5339
[Pubmed]  [Google Scholar] [DOI]


Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow